NCT03434015View on ClinicalTrials.gov

Post-approval Study of Percutaneous Left Atrial Appendage Closure ( FLAAC-2 )

CompletedOBSERVATIONAL
Enrollment

1,051

Participants

Timeline

Start Date

July 9, 2018

Primary Completion Date

February 15, 2020

Study Completion Date

October 7, 2021

Conditions
Atrial Fibrillation
Trial Locations (1)

Unknown

Henri Mondor Hospital, Créteil

All Listed Sponsors
lead

French Cardiology Society

OTHER

NCT03434015 - Post-approval Study of Percutaneous Left Atrial Appendage Closure ( FLAAC-2 ) | Biotech Hunter | Biotech Hunter